Journal of Stem Cell Research & Therapy

Highly efficient and marker-free genome editing of human pluripotent stem cells by CRISPR-Cas9 RNP and AAV6 donor-mediated homologous …

AAV integration in human hepatocytes

Therapy Development by Genome Editing of Hematopoietic Stem Cells

Gene editing on center stage

IRF and STAT transcription factors-from basic biology to roles in infection, protective immunity, and primary immunodeficiencies

Global transcriptional response to CRISPR/Cas9-AAV6-based genome editing in CD34+ hematopoietic stem and progenitor cells

Site-specific gene editing of human hematopoietic stem cells for X-linked hyper-IgM syndrome

Gene editing and CRISPR in the clinic: current and future perspectives

Gene therapy targeting haematopoietic stem cells for inherited diseases: progress and challenges

CRISPR-Cas9 based genome editing for defective gene correction in humans and other mammals

 Gene correction for SCID-X1 in long-term hematopoietic stem cells

Precise gene editing preserves hematopoietic stem cell function following transient p53-mediated DNA damage response

A new class of medicines through DNA editing

A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells

Comparative Effectiveness Research: A Pharmaceutical Industry Perspective on Outlook, Dilemmas, and Controversies

Estimates for quality of life loss due to Respiratory Syncytial Virus

Perceptions of the impact of disability and impairment on health, quality of life and capability

Road to stemness in hepatocellular carcinoma

Health-related quality of life measures for a costeffectiveness analysis of ischemic stroke therapies

Glioblastoma Stem Cells and Their Microenvironment